These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2578746)

  • 1. A search for interferon in the CSF of chronic schizophrenic patients.
    Roy A; Pickar D; Ninan P; Hooks J; Paul SM
    Am J Psychiatry; 1985 Feb; 142(2):269. PubMed ID: 2578746
    [No Abstract]   [Full Text] [Related]  

  • 2. CSF prostaglandin levels in depressed and schizophrenic patients.
    Linnoila M; Whorton AR; Rubinow DR; Cowdry RW; Ninan PT; Waters RN
    Arch Gen Psychiatry; 1983 Apr; 40(4):405-6. PubMed ID: 6838321
    [No Abstract]   [Full Text] [Related]  

  • 3. (Auto)aggression and CSF 5-HIAA in depression and schizophrenia.
    van Praag HM
    Psychopharmacol Bull; 1986; 22(3):669-73. PubMed ID: 2432628
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevation of substance P-like peptides in the CSF of psychiatric patients.
    Rimón R; Le Grevés P; Nyberg F; Heikkilä L; Salmela L; Terenius L
    Biol Psychiatry; 1984 Apr; 19(4):509-16. PubMed ID: 6203562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.
    Banki CM; Bissette G; Arato M; O'Connor L; Nemeroff CB
    Am J Psychiatry; 1987 Jul; 144(7):873-7. PubMed ID: 3496802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interferon in patients with psychosis.
    Preble OT; Torrey EF
    Am J Psychiatry; 1985 Oct; 142(10):1184-6. PubMed ID: 2412455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid neuropeptide Y in depression and schizophrenia.
    Berrettini WH; Doran AR; Kelsoe J; Roy A; Pickar D
    Neuropsychopharmacology; 1987 Dec; 1(1):81-3. PubMed ID: 3509070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome.
    Nemeroff CB; Bissette G; Widerlov E; Beckmann H; Gerner R; Manberg PJ; Lindstrom L; Prange AJ; Gattaz WF
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):16-20. PubMed ID: 2577718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of CSF somatostatin concentrations in mania.
    Sharma RP; Bissette G; Janicak PG; Davis JM; Nemeroff CB
    Am J Psychiatry; 1995 Dec; 152(12):1807-9. PubMed ID: 8526251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa.
    Gerner RH; Hare TA
    Am J Psychiatry; 1981 Aug; 138(8):1098-101. PubMed ID: 7258390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF beta-endorphin-immunoreactivity in normal, schizophrenic, depressed, manic and anorexic subjects.
    Gerner RH; Sharp B
    Brain Res; 1982 Apr; 237(1):244-7. PubMed ID: 6280804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can CSF measures distinguish among schizophrenia, depression, movement disorders, and dementia?
    Stahl SM
    Psychopharmacol Bull; 1985; 21(3):396-9. PubMed ID: 2863846
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated cerebrospinal fluid protein in men with unipolar or bipolar depression.
    Samuelson SD; Winokur G; Pitts AF
    Biol Psychiatry; 1994 Apr; 35(8):539-44. PubMed ID: 8038297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrections to a 1980 article on CSF monoamine metabolites.
    Faull KF; Berger PA; Kilkowski J; Anderson PJ; Kraemer H; Davis KL; Barchas JD
    Am J Psychiatry; 1989 Jan; 146(1):118. PubMed ID: 2463774
    [No Abstract]   [Full Text] [Related]  

  • 15. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls.
    Gerner RH; Fairbanks L; Anderson GM; Young JG; Scheinin M; Linnoila M; Hare TA; Shaywitz BA; Cohen DJ
    Am J Psychiatry; 1984 Dec; 141(12):1533-40. PubMed ID: 6209989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients.
    Doran AR; Rubinow DR; Roy A; Pickar D
    Arch Gen Psychiatry; 1986 Apr; 43(4):365-9. PubMed ID: 2869743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid prostaglandin E in depression, mania, and schizophrenia compared to normals.
    Gerner RH; Merrill JE
    Biol Psychiatry; 1983 May; 18(5):565-9. PubMed ID: 6860728
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid inositol monophosphatase: elevated activity in depression and neuroleptic-treated schizophrenia.
    Atack JR; Levine J; Belmaker RH
    Biol Psychiatry; 1998 Sep; 44(6):433-7. PubMed ID: 9777174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.
    Bissette G; Widerlöv E; Walléus H; Karlsson I; Eklund K; Forsman A; Nemeroff CB
    Arch Gen Psychiatry; 1986 Dec; 43(12):1148-51. PubMed ID: 3778111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers.
    Naber D; Pickar D; Post RM; Van Kammen DP; Waters RN; Ballenger JC; Goodwin FK; Bunney WE
    Am J Psychiatry; 1981 Nov; 138(11):1457-62. PubMed ID: 6271019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.